KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX)

CUSIP: 492515101

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COMMON STOCK
Total 13F shares
74,365,398
Share change
-912,687
Total reported value
$252,825,495
Put/Call ratio
131%
Price per share
$3.40
Number of holders
117
Value change
-$3,991,681
Number of buys
40
Number of sells
63

Quarterly Holders Quick Answers

What is CUSIP 492515101?
CUSIP 492515101 identifies KERX - KERYX BIOPHARMACEUTICALS - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q3 2018

As of 30 Sep 2018, KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 74,365,398 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, ABRAMS CAPITAL MANAGEMENT, L.P., Vanguard Group Inc, BlackRock Inc., STATE STREET CORP, RICE HALL JAMES & ASSOCIATES, LLC, NORGES BANK, PKO Investment Management Joint-Stock Co, NORTHERN TRUST CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 117 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.